Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Early Manifest Huntington Disease”

16 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 16 of 16 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05243017
What this trial is testing

Safety and Efficacy of AMT-130 in European Adults With Early Manifest Huntington's Disease

Who this might be right for
Huntington Disease
UniQure Biopharma B.V. 14
Early research (Phase 1)Study completedNCT03664804
What this trial is testing

Study to Measure Cerebrospinal Fluid Mutant Huntingtin Protein in Participants With Early Manifest Stage I or Stage II Huntington's Disease

Who this might be right for
Huntington's Disease
Hoffmann-La Roche 95
Very early researchStudy completedNCT07344519
What this trial is testing

The Safety and Tolerability Study With ER2001 Intravenous Injection Repetitive Treatment in Adults With Early Manifest Huntington's Disease.

Who this might be right for
Huntington Disease
ExoRNA Bioscience 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT05541627
What this trial is testing

Evaluate AB-1001 Striatal Administration in Adults With Early Manifest Huntington's Disease

Who this might be right for
Huntington Disease
AskBio France, SAS, a subsidiary of AskBio Inc. 5
Testing effectiveness (Phase 2)Study completedNCT02519036
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ISIS 443139 in Participants With Early Manifest Huntington's Disease

Who this might be right for
Huntington's Disease
Ionis Pharmaceuticals, Inc. 46
Testing effectiveness (Phase 2)Active Not RecruitingNCT05686551
What this trial is testing

GENERATION HD2. A Study to Evaluate the Safety, Biomarkers, and Efficacy of Tominersen Compared With Placebo in Participants With Prodromal and Early Manifest Huntington's Disease

Who this might be right for
Huntington Disease
Hoffmann-La Roche 301
Early research (Phase 1)Study completedNCT01485952
What this trial is testing

An Exploratory Clinical Trial in Early Stage Huntington's Disease Patients With SEN0014196

Who this might be right for
Huntington Disease
Siena Biotech S.p.A. 55
Early research (Phase 1)WithdrawnNCT04885114
What this trial is testing

Safety and Tolerability Study With VY-HTT01, in Adults With Early Manifesting Huntington's Disease

Who this might be right for
Huntington Disease
Voyager Therapeutics
Very early researchStudy completedNCT06024265
What this trial is testing

The Safety and Tolerability Study With ER2001 Intravenous Injection in Adults With Early Manifest Huntington's Disease

Who this might be right for
Huntington Disease
ExoRNA Bioscience 10
Testing effectiveness (Phase 2)Ended earlyNCT05111249
What this trial is testing

A Dose Range Finding Study With Open-Label Extension to Evaluate the Safety of Oral LMI070/Branaplam in Early Manifest Huntington's Disease

Who this might be right for
Early Manifest Huntington Disease
Novartis Pharmaceuticals 26
Not applicableLooking for participantsNCT06203106
What this trial is testing

NYSCF Scientific Discovery Biobank

Who this might be right for
ALSAmyotrophic Lateral SclerosisAlzheimer Disease+26 more
New York Stem Cell Foundation Research Institute 10,000
Not applicableStudy completedNCT02881931
What this trial is testing

FuRST 2.0 Cognitive Pre-Testing

Who this might be right for
Huntington's Disease
CHDI Foundation, Inc. 75
Testing effectiveness (Phase 2)Active Not RecruitingNCT07339514
What this trial is testing

A Phase I Clinical Study of ER2001 Injection for the Treatment of Early Manifest Huntington's Disease.

Who this might be right for
Huntington Disease
ExoRNA Bioscience 27
Not applicableLooking for participantsNCT07253038
What this trial is testing

Evaluation of Three Tests to Assess Social Cognition in Huntington Disease

Who this might be right for
Huntington Disease
Region Skane 40
Testing effectiveness (Phase 2)Study completedNCT02481674
What this trial is testing

A Study in Subjects With Late Prodromal & Early Manifest HD to Assess the Safety, Tolerability, pk, and Efficacy of Pepi

Who this might be right for
Huntington's Disease
Vaccinex Inc. 301
Testing effectiveness (Phase 2)Active Not RecruitingNCT04120493
What this trial is testing

Safety and Proof-of-Concept (POC) Study With AMT-130 in Adults With Early Manifest Huntington's Disease

Who this might be right for
Huntington's Disease
UniQure Biopharma B.V. 43